Nanotechnology in triple-negative breast cancer: a review of nanocarrier systems for enhanced efficacy and reduced toxicity
Nanoscale Advances · 2026 · 8 (10) · 3073-3101
DOI: 10.1039/d5na00907c ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanoscale Advances, 2026. Verfasst von Qazi Saifullah und 5 weiteren Autor:innen. Beteiligte Einrichtung: GITAM School of Pharmacy, GITAM (deemed to be University) Rushikonda Visakhapatnam-530045 Andhra Pradesh India proy@gitam.edu partharoy2502@gmail.com. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 265 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
The aggressive and extremely diverse subtype of breast cancer known as triple-negative breast cancer (TNBC) lacks HER2, progesterone, and oestrogen receptors, which limits treatment options and increases the risk of metastasis and recurrence.
Autor:innen und Institutionen
- GITAM School of Pharmacy, GITAM (deemed to be University) Rushikonda Visakhapatnam-530045 Andhra Pradesh India proy@gitam.edu partharoy2502@gmail.com.
- Basic Science and Humanities Department, University of Engineering and Management Kolkata West Bengal 700160 India.
ORCID-Profile: Qazi Saifullah, Sajid Mondal, Amartya Nandi, Yeduvaka Madhuri, Suvadra Das, Partha Roy
Zitieren
APA
Saifullah, Q., Mondal, S., Nandi, A., Madhuri, Y., Das, S., & Roy, P. (2026). Nanotechnology in triple-negative breast cancer: a review of nanocarrier systems for enhanced efficacy and reduced toxicity. Nanoscale Advances, 8(10), 3073-3101. https://doi.org/10.1039/d5na00907c
Vancouver
Saifullah Q, Mondal S, Nandi A, Madhuri Y, Das S, Roy P. Nanotechnology in triple-negative breast cancer: a review of nanocarrier systems for enhanced efficacy and reduced toxicity. Nanoscale Advances. 2026;8(10):3073-3101. doi:10.1039/d5na00907c
BibTeX
@article{Saifullah2026,
author = {Saifullah, Qazi and Mondal, Sajid and Nandi, Amartya and Madhuri, Yeduvaka and Das, Suvadra and Roy, Partha},
title = {Nanotechnology in triple-negative breast cancer: a review of nanocarrier systems for enhanced efficacy and reduced toxicity},
journal = {Nanoscale Advances},
year = {2026},
volume = {8},
number = {10},
pages = {3073--3101},
doi = {10.1039/d5na00907c}
}
EUVIMED